Abacavir Sulfate CAS Number 188062-50-2
Wiki Article
Abacavir sulfate, chemically defined as registration number 188062-50-2, acts as a highly effective HIV medication. It blocks the multiplication of the human immunodeficiency virus (HIV) by preventing the viral enzyme reverse transcriptase. This enzyme plays a vital role in the HIV life cycle, allowing the virus to integrate its genetic material into the host's DNA. Abacavir sulfate is typically administered in combination with other antiretroviral drugs as part of a comprehensive treatment regimen for HIV infection.
Avastin : Chemical Identifier 183552-38-7
Abarelix, also known by its chemical identifier 183552-38-7, is a/represents/serves as a gonadotropin-releasing hormone (GnRH) antagonist. It functions by/operates through/acts upon blocking the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This ultimately reduces/suppresses/minimizes testosterone production in men, making it a valuable treatment option for prostate cancer. Abarelix is typically administered/delivered/infused as an injection, usually on a monthly basis.
Abiraterone Acetate: Chemical Identity
Abiraterone acetate functions as an medication employed in the management of advanced cancer. That substance intervenes by blocking an protein known as 17-alpha-hydroxylase/17,20-lyase, that prevents the production of androgens, hormones responsible for fueling prostate cancer growth. CAS Registry Number 154229-18-2 serves the unique code of abiraterone acetate, confirming its accurate identification within scientific communities.
Examination of Abacavir Sulfate's Chemical Properties
Abacavir sulfate, with the chemical identifier CAS 188062-50-2, is recognized as a vital component in the treatment of HIV infection. This potent medication suppresses the replication of the human immunodeficiency virus (HIV). Abacavir sulfate falls under the class of nucleoside reverse transcriptase inhibitors (NRTIs).
Its chemical structure consists of a complex arrangement of molecules. The molecule exhibits characteristic physicochemical properties that contribute to its biological activity and therapeutic efficacy.
Understanding the chemical profile of abacavir sulfate extends valuable insights into its mechanism of action, pharmacokinetics, and potential effects with other substances.
Pharmaceutical Compound Identification: Abaarelix (CAS 183552-38-7)
Abaarelix, identified by the CAS registry number 183552-38-7, is a significant pharmaceutical compound within the realm of medicine. Its primary purpose revolves around the modulation of hormone levels, particularly targeting gonadotropin-releasing hormone (GnRH). This unique mechanism makes Abaarelix essential in the treatment of various conditions, notably those involving androgen-dependent growth or development.
- Studies into Abaarelix have demonstrated its efficacy in ameliorating symptoms associated with prostate cancer, endometriosis, and certain types of infertility.
- Moreover, the compound's distribution properties have been extensively evaluated to ensure its safety and tolerability in clinical settings.
Therefore, Abaarelix has emerged as a effective therapeutic approach in the modern medical landscape, delivering hope and improved quality of life to patients grappling with these serious diseases.
Abiraterone Acetate: Structure and Properties CAS No. 154229-18-2
Abiraterone acetate, identified by the chemical identifier CAS No. 154229-18-2, is a potent synthetic compound. It exhibits a complex configuration characterized by a copyright framework. This APRACLONIDINE HCL 73218-79-8 framework encompasses numerous functional groups, contributing to its biological properties.
Abiraterone acetate is a non-copyrightal restrainer of the enzyme 17α-CYP17A1 (CYP17A1), which plays a crucial role in the synthesis of androgens, primarily testosterone. By effectively inhibiting CYP17A1, abiraterone acetate suppresses androgen production within the body, thus offering potential therapeutic benefits in the management of prostate cancer.
Report this wiki page